Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Raw Materials: 2009-2024

Historic Raw Materials for Fresenius Medical Care AG (FMS) over the last 16 years, with Q4 2024 value amounting to $446.1 million.

  • Fresenius Medical Care AG's Raw Materials fell 812.97% to $446.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $446.1 million, marking a year-over-year decrease of 812.97%. This contributed to the annual value of $451.8 million for FY2024, which is 694.82% down from last year.
  • Fresenius Medical Care AG's Raw Materials amounted to $446.1 million in Q4 2024, which was down 812.97% from $485.6 million recorded in Q4 2023.
  • Fresenius Medical Care AG's Raw Materials' 5-year high stood at $565.0 million during Q4 2022, with a 5-year trough of $446.1 million in Q4 2024.
  • Moreover, its 5-year median value for Raw Materials was $517.2 million (2021), whereas its average is $515.6 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 2755.01% in 2020, then crashed by 1406.03% in 2023.
  • Fresenius Medical Care AG's Raw Materials (Quarter) stood at $564.1 million in 2020, then dropped by 8.33% to $517.2 million in 2021, then grew by 9.26% to $565.0 million in 2022, then fell by 14.06% to $485.6 million in 2023, then fell by 8.13% to $446.1 million in 2024.
  • Its Raw Materials was $446.1 million in Q4 2024, compared to $485.6 million in Q4 2023 and $565.0 million in Q4 2022.